mHealth to Early Detect Exacerbation for Older People With Heart Failure
mobileHF
(in Spanish) Utilidad de un Instrumento telediagnóstico en la detección de la reagudización de la Insuficiencia Cardiaca crónica en Ancianos
3 other identifiers
interventional
90
0 countries
N/A
Brief Summary
The aim of the study was to demonstrate the effectiveness of telemonitoring functional status and vital signs to early detect heart failure exacerbation, and to minimize readmissions and length of hospitalisations. Patients over 75 with heart failure were included after a hospitalisation due to heart failure exacerbation. Patients were assigned randomly into intervention or control. The intervention group comprised 47 patients who were assessed through telemonitoring, while 40 followed traditional clinical pathways. Patients were followed-up for 3 months after discharge, collecting emergency visits and readmissions due to a new heart failure exacerbation. Those patients in the intervention group used a commercial telemedicine system: Careline H@me, which was provided by the company SALUDNOVA. They system was personalized by adding the functional status monitoring capabilities. Thus, the system collected vital signs (i.e. blood pressure, heart rate, respiratory rate, oxygen saturation, glucose, and weight); symptoms of decompensated heart failure (i.e. dyspnoea and orthopnoea); and functional status (i.e. part of the Short Physical Performance Battery, SPPB) and a brief questionnaire (i.e. Do you have the medication?) every 48 hours. Two staff geriatricians at the Hospital Universitario de Getafe accessed, during working days, a secured dedicated web-portal to assess the progression of their patients, evaluated through the monitored variables and the self reported symptoms. They reacted to the data, if needed, making a phone call or visiting the patient. Besides, patients could contact the geriatricians or attending the emergency room as usually. After completion, we analysed the results. First, we carried out a descriptive analysis of the data. Later, we analysed the effects of the intervention with telemedicine and the predictive values of the different measured variables through logistic regressions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Aug 2010
Typical duration for not_applicable heart-failure
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 22, 2015
CompletedFirst Posted
Study publicly available on registry
July 23, 2015
CompletedJuly 23, 2015
July 1, 2015
3.2 years
July 22, 2015
July 22, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Readmissions
Number of visits to the emergency room that require readmission
3 months
Secondary Outcomes (3)
Emergency visits
3 months
Worsening
3 months
Readmissions length
3 months
Study Arms (2)
Intervention using mHealth
ACTIVE COMPARATORPatients in the intervention used at home a mobile system to monitor their clinical and health status.
Control
NO INTERVENTIONPatients in the control group received the usual care.
Interventions
Patients in the intervention used at home a mobile system to monitor their clinical and health status.
Eligibility Criteria
You may qualify if:
- Patients admitted at the acute care unit at the Hospital Universitario de Getafe who are diagnosed with Heart Failure as primary cause for admission.
You may not qualify if:
- Moderate/severe cognitive impairment (MMSE\<23)
- Visual/auditory deficits, communication problems
- Moderate/severe non-reversible functional impairment (Barthel\<60)
- To be institutionalized
- To be discharged to a Functional Rehabilitation Hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Universitario Getafelead
- SALUDNOVA SOLUTION S.Lcollaborator
- Instituto de Salud Carlos IIIcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2015
First Posted
July 23, 2015
Study Start
August 1, 2010
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
July 23, 2015
Record last verified: 2015-07